https://www.cslbehring.ae/our-company/leading-the-way-on-rare-and-serious-diseases
Leading the Way on Rare & Serious Diseases
Our scientists use the latest technologies to develop and deliver therapies that are used to treat rare and serious conditions, including immunodeficiency and...
rare serious diseasesleading
https://pulmocide.com/
Developing targeted therapies for serious respiratory diseases | Pulmocide
Dec 5, 2024 - Pulmocide is a biotechnology company developing novel inhaled medicines for pulmonary aspergillosis and other hard-to-treat respiratory diseases.
targeted therapiesdeveloping
https://www.cslbehring.com.sg/our-company/leading-the-way
Leading the Way on Rare & Serious Diseases
Our scientists use the latest technologies to develop and deliver therapies that are used to treat rare and serious conditions, including immunodeficiency and...
rare serious diseasesleading
https://www.cslbehring.ca/our-company/leading-the-way
Leading the Way on Rare & Serious Diseases
Our scientists use the latest technologies to develop and deliver therapies that are used to treat rare and serious conditions, including immunodeficiency and...
rare serious diseasesleading
https://www.csl.com/patients-public-health/rare-and-serious-diseases
Rare and Serious Diseases | CSL
CSL Behring is proud to serve the rare and serious diseases community with treatments in numerous therapeutic areas.
serious diseasesrarecsl